Rivastigmine 13.3mg/24h transdermal patch (Voleze®)

Shared care guideline available

  • Traffic Light
    Amber (SCG)
  • BNF
  • Licensed Indicators
    Mild to moderate severe alzhemiers disease
  • Reference
    APC Jan 15
  • Criteria
  • Provisional
    No

Do you want to add this to your CPD record?

Did you find this page helpful?